Key facts
- Monteris Medical’s last known valuation is $60.6M (Jun 2017).
- It has raised $275.0M across 1 recorded rounds; the latest was Seed Round ($3.7M) in Oct 2013.
- Notable investors include OSF Ventures, InnovaHealth Partners, Birchview Capital, CU Healthcare Innovation Fund, Madryn Asset Management.
- Monteris Medical has filed 1 Form D with the SEC, most recently Oct 2013 ($3.7M sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Monteris Medical
Funding rounds
1 roundsAbout Monteris Medical
Developer of magnetic resonance imaging-guided, laser-based systems designed for the ablation of brain lesions. The company's system applies focused laser energy to ablate brain tumors from the inside, with little or no effect on surrounding healthy tissue and provides clinicians with a neurosurgical tool that offers real-time control and visualization of the therapy during laser ablation treatment, enabling neurosurgeons to ablate brain lesions and brain tumors that may be difficult to approach via traditional methods.
- Sector
- Healthcare
- HQ
- Minnetonka, MN, United States
- Founded
- 1999
- Employees
- 120
- Website
- monteris.com/
- Ownership
- Privately Held (backing)
Monteris Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Monteris Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Monteris Medical in its N-PORT filings yet. We sweep new filings monthly.